US EditionPublished • loading... • Updated
How Genexis Is Cutting Cell Culture Protein Costs By 10X With Engineered Microbes
Summary by Inc42 Media
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
How Genexis Is Cutting Cell Culture Protein Costs By 10X With Engineered Microbes
As the Covid-19 pandemic swept across the globe with unprecedented speed and impact, countries raced to develop vaccines only to run into an unforeseen bottleneck. International trade slowed to a crawl, and global supply chains collapsed almost immediately when the virus spread. Acquiring key ingredients for vaccines became increasingly challenging, ruthlessly exposing the myth of industrial self-sufficiency. In India, the crisis was more acute.…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
